FMP

FMP

Enter

LPTX - Leap Therapeutics, I...

photo-url-https://images.financialmodelingprep.com/symbol/LPTX.png

Leap Therapeutics, Inc.

LPTX

NASDAQ

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

2.46 USD

-0.09 (-3.66%)

LPTX Financial Statements

Year

2023

2022

2021

2020

Total Revenue

0

0

1.5M

1.5M

Cost of Revenue

427k

415k

0

0

Gross Profit

-427k

-415k

1.5M

1.5M

Operating Expenses

86.61M

54.71M

41.7M

29.81M

Research and Development

73.23M

44.97M

32.16M

20.42M

Selling, General & Administrative Expenses

13.38M

11.8M

10.77M

9.62M

Selling & Marketing Expenses

-427k

0

0

0

General & Administrative Expenses

13.81M

11.8M

10.77M

9.62M

Other Expenses

0

-2.05M

-1.23M

-231k

Operating Income

-87.04M

-56.76M

-41.43M

-28.54M

Total Other Income/Expenses Net

5.63M

2.31M

815k

1.02M

Income Before Tax

-81.41M

-54.45M

-40.61M

-27.52M

Income Tax

0

147k

-24k

-2k

Net Income

-81.41M

-54.6M

-40.59M

-27.51M

Basic EPS

-3.98

-4.82

-4.73

-4.64

EPS Diluted

-3.98

-4.82

-4.73

-4.64

Basic Average Shares

20.45M

11.32M

8.58M

5.93M

Diluted Average Shares

20.45M

11.32M

8.58M

5.93M

EBITDA

-80.99M

-53.98M

-40.01M

-26.81M

Retained Earning Schedule

Year

2023

2022

2021

2020

Retained Earnings (Previous Year)

-318.17M

-263.57M

-222.99M

-195.17M

Net Income

-81.41M

-54.6M

-40.59M

-27.51M

Stock Repurchases

-1k

0

0

0

Dividend Paid

0

0

0

-303k

Retained Earnings

-399.58M

-318.17M

-263.57M

-222.99M

Other Distributions

-81.42M

-54.6M

-40.59M

-28.12M

PPE Schedule

Year

2023

2022

2021

2020

Gross PPE

262k

689k

495k

593k

Annual Depreciation

427k

415k

556k

668k

Capital Expenditure

0

0

0

0

Net PPE

-165k

274k

-61k

-75k

Intangible and Goodwill Schedule

Year

2023

2022

2021

2020

Acquisitions and Adjustments

0

0

0

0

Goodwill (Previous Year)

0

0

0

0

Goodwill

0

0

0

0

All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep